Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2026-02-26 @ 3:17 AM
Study NCT ID:
NCT05048056
Status:
TERMINATED
Last Update Posted:
2025-02-26
First Post:
2021-09-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis
Sponsor:
Akesobio Australia Pty Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AK120-203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None